Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

FDA Approves First-of-Its-Kind, Adult Pneumonia Antibiotic; September Launch Planned

The drug's features and its developer's commercial plans are discussed in an H.C. Wainwright & Co. report. In an Aug. 20 research note, analyst Ed Arce reported that H.C. Wainwright & Co. raised its target price on Nabriva Therapeutics Plc (NBRV:NASDAQ) to $8 per sh...

Economic stimulus can’t save US from deflation and recession

One of the worst weeks on Wall Street mercifully ended on Friday. S&P 500 DJIA Nasdaq After multiple sessions of panic selling, the markets caught an up-draft after US President Trump declared a national emergency over the coronavirus, thus freeing u...

PhaseBio Shares Are on a Tear After Reporting Phase 2a Trial Results

The clinical-stage biopharmaceutical stock surged more than 30% Wednesday following a report that PB2452 caused immediate and sustained reversal of ticagrelor in older and elderly subjects. In a press release issued September 24, PhaseBio Pharmaceuticals Inc. (PHAS...

After China Trade Deal, Trump Takes Aim at Europe

The Trump administration has taken a tough stance in international trade negotiations. With the US-China deal sealed and Congress set to vote on the US-Mexico-Canada accord, will the European Union be President Trump’s next target? Kenny Fisher ...

Silver Dips Lower but Remains Close to 17.00 Level

Silver prices have dropped slightly, as the metal trades around $16.90. The dramatic vote to impeach President Trump did not stir silver, which continues to trade close to the symbolic $17 level. Kenny Fisher Silver has recorded los...

Pandemics and Gold: Part 1

The outbreak of COVID-19 has brutally reminded people of the risk of a pandemic. However, investors should never panic but look to history as a guide. We invite you thus to read our today’s article, which provides an important analysis of the history of pandemi...

Global Shutdown and Gold

Have you read Ayn Rand’s novel Atlas Shrugged ? The main theme of the book is that – overwhelmed by growing statism – entrepreneurs at one point say finally “basta!” and announce a strike. The symbolic Atlas who carries the world, sh...

Trump Impeached in the House! Is It Time for Gold Now?

Last week, the House voted to impeach Donald Trump. This is the third time in the U.S. history such an event has happened to the sitting President. What does it imply for the gold market? Trump’s Impeachment, Explained On Wednesday, the House of Represe...

Pandemic fears: real and imagined

“Pandemic”. Few words in the English language conjure as much fear. The mere utterance evokes images of dying patients, surgical masks, haz-mat suits, a parade of coffins, helpless doctors and nurses, as the contagion spreads, first striking down the el...

Oil Price Fundamental Daily Forecast – ...

Oil Price Fundamental Daily Forecast – Supply/Demand Picture Rosy; Low Volume Biggest Concern for Traders Speculative buyers have been driving prices higher for weeks on the hope of supply cuts and a trade deal. Low pre-holiday volume could cause these buyers to curtail...
1 2 3 4 5 6